Gastroenterology
Volume 132, Issue 4 , Pages 1320-1330, April 2007

Helminth Infection Enhances Disease in a Murine TH2 Model of Colitis

  • Meaghan M. Hunter

      Affiliations

    • Intestinal Disease Research Programme, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Arthur Wang

      Affiliations

    • Intestinal Disease Research Programme, McMaster University, Hamilton, Ontario, Canada
    • Gastrointestinal Research Group, University of Calgary, Calgary, Alberta, Canada
  • ,
  • Derek M. Mckay

      Affiliations

    • Intestinal Disease Research Programme, McMaster University, Hamilton, Ontario, Canada
    • Gastrointestinal Research Group, University of Calgary, Calgary, Alberta, Canada
    • Corresponding Author InformationAddress requests for reprints to: Derek M. McKay, PhD, Gastrointestinal Research Group, HS 1877, Department of Physiology and Biophysics, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1. fax: (403) 210-8119.

Received 12 June 2006; accepted 14 December 2006. published online 26 January 2007.

Background & Aims: There is convincing evidence from animal and human studies that infection with parasitic helminths can alleviate the histopathology and symptoms of colitis. Here the ability of the rat tapeworm Hymenolepis diminuta to affect the course of oxazolone-induced colitis (a TH2 model) was assessed. Methods: Mice were infected with H diminuta and 8 days later they received oxazolone (3 mg in 50% EtOH, intrarectal). On autopsy (3 or 7 days postoxazolone), disease severity was assessed by macroscopic clinical scores, histologic damage scores, myeloperoxidase and eosinophil peroxidase activity, and cytokine synthesis. Results: As gauged by all markers of gut function, infection with H diminuta caused a significant exacerbation of oxazolone-induced colitis. Indeed, while mice receiving oxazolone only began to recover ∼3–4 days posttreatment, the cotreated group continued to deteriorate. Helminth infection, independent of oxazolone administration, enhanced IL-4, IL-5, IL-10, and IL-13 production from in vitro stimulated immune cells and evoked increases in colonic eosinophil peroxidase of cotreated mice. Finally, while knockout of natural killer (NK) and NK-T cells by administration of a neutralizing NK1.1 antibody reduced the inflammation in oxazolone and oxazolone + H diminuta-treated animals, mice in the latter group still displayed significant colitis. Conclusions: We have shown that H diminuta infection is beneficial in other models of colitis. The current data is presented as a caveat to the position that parasitic helminths in general can be considered as a therapy for heterogeneous inflammatory disorders without careful analysis of the immunologic basis of the condition.

Abbreviations used in this paper: AB, antibodies, AMT, 3-amino-1,2,4-triazole, ELISA, enzyme-linked immunosorbent assay, EPO, eosinophil peroxidase, IBD, inflammatory bowel disease, IL, interleukin, IR, intrarectal, MLNs, mesenteric lymph nodes, MPO, myeloperoxidase, NK, natural killer, RT-PCR, reverse transcriptase polymerase chain reaction, SEM, standard error of the mean, TGFβ, transforming growth factor, TH, T helper, TNFα, tumor necrosis factor alpha

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Grant support was provided by the Crohn’s and Colitis Foundation of Canada to D.M. McKay. D.M. McKay is a recipient of a Canada Research Chair (Tier 1) in Intestinal Immunophysiology and is an Alberta Heritage Foundation for Medical Research (AHFMR) Scientist, and M.M. Hunter is supported by a Natural Sciences and Engineering Research Council (NSERC) of Canada doctoral studentship.

PII: S0016-5085(07)00177-1

doi:10.1053/j.gastro.2007.01.038

Gastroenterology
Volume 132, Issue 4 , Pages 1320-1330, April 2007